US equities |
NVDA $238.29 ▲+1.86% SPCX $167.63 ▲+5.45% MU $1,063.31 ▼-1.08% TSLA $379.75 ▲+2.47% MSFT $525.10 ▲+1.46% SNDK $1,712.52 ▼-0.43% INTC $117.08 ▼-1.88% META $743.29 ▲+2.09%
FinancialContent

IQVIA Holdings, Inc. Common Stock (NY:IQV)

263.56 +5.35 (+2.07%)
Delayed Quote Updated: 2:24 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗
 
Via Benzinga
News headline image
IQVIA CFO Ron Bruehlman to Speak at Baird Global Healthcare Conference on September 13, 2023
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Peering Into IQVIA Hldgs's Recent Short Interest ↗
 
Via Benzinga
News headline image
Earnings Outlook For IQVIA Hldgs ↗
 
Via Benzinga
News headline image
(IQV) - Analyzing IQVIA Hldgs's Short Interest ↗
 
Via Benzinga
News headline image
What 7 Analyst Ratings Have To Say About IQVIA Hldgs ↗
 
Via Benzinga
News headline image
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
From IQVIA
Via Business Wire
News headline image
3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of ↗
Worries about biotech stocks are way overdone, so the sector should make a big comeback in the coming months. 
Via InvestorPlace
News headline image
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
IQVIA Q2: 5.3% Sales Growth, Additional Share Repurchase, Reduced FY23 Guidance & More ↗
IQVIA Holdings, Inc. (NYSE: IQV) posted Q2 sales of $3.728 billion, up 5.3% Y/Y on a reported basis and 5.5% at constant currency (CC),  
Via Benzinga
News headline image
IQVIA Reports Second-Quarter 2023 Results
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Datadog, IQVIA, Organon And An Oilfield Services Giant Rolling Out An AI Platform: CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes IQVIA Holdings Inc. (NYSE: IQV) 
Via Benzinga
News headline image
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
From IQVIA Holdings Inc.
Via Business Wire
News headline image
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
$1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Is Veeva Systems a Buy Now? ↗
The stock is trading at a high multiple despite revenue that's growing by mid-single-digit percentages. 
Via The Motley Fool
News headline image
IQVIA and the NBA Selected for Abbott’s UNIVANTS of Healthcare Excellence Award
From IQVIA
Via Business Wire
News headline image
IQVIA selected ‘Leader’ in Everest Group Life Sciences Sales and Marketing Operations PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
News headline image
IQVIA Wins Prestigious “Best AI-based Solution for Healthcare” Award in 2023 Artificial Intelligence Breakthrough Awards
From IQVIA
Via Business Wire
News headline image
Here's How Much $1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
IQVIA Hldgs's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
IQVIA Launches RIM Smart Labeling to Deliver Intelligence-Driven Approach for Global Label Management
From IQVIA
Via Business Wire
News headline image
2 Soaring Healthcare Stocks That Could Climb Even Higher ↗
These stocks are coming off a big week that could be the beginning of a bigger rally. 
Via The Motley Fool
News headline image
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
From IQVIA
Via Business Wire
News headline image
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
News headline image
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
News headline image
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
From IQVIA
Via Business Wire
News headline image
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
From IQVIA
Via Business Wire
News headline image
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
From IQVIA
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >